The aim of this review is to collect and present recent evidence in the literature regarding resveratrol and its effects on cancer prevention, molecular signaling (especially regarding the involvement of the p53 protein), and therapeutic perspectives, with an emphasis on clinical trial results. Here, TP53 is linked to cancer.